Filgotinib Versus Placebo in Adults With Active Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Biologic Disease-modifying Anti-rheumatic Drug(s) (DMARDs) Treatment

Completed · Phase 3 · Has a placebo group

Conditions studied: Rheumatoid Arthritis

In brief

The primary objective of this study is to evaluate the effects of filgotinib versus placebo for the treatment of signs and symptoms of rheumatoid arthritis (RA) as measured by the percentage of participants achieving an American College of Rheumatology 20% improvement response (ACR20) at Week 12.

Key facts

Study ID

NCT02873936

Run by

Gilead Sciences

People needed

449

Starts

2016-07-27

Expected to finish

2018-06-26

Last updated by the study team

2021-05-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Study site — Gilbert, Arizona, United States
• Study site — Covina, California, United States
• Study site — Hemet, California, United States
• Study site — La Jolla, California, United States
• Study site — Palm Desert, California, United States
• Study site — Palo Alto, California, United States
• Study site — Riverside, California, United States
• Study site — Upland, California, United States
• Study site — Victorville, California, United States
• Study site — Whittier, California, United States
• Study site — Aventura, Florida, United States
• Study site — DeBary, Florida, United States
• Study site — Jacksonville, Florida, United States
• Study site — Miami, Florida, United States
• Study site — Orlando, Florida, United States
• Study site — Plantation, Florida, United States
• Study site — Port Richey, Florida, United States
• Study site — Decatur, Georgia, United States
• Study site — Kansas City, Kansas, United States
• Study site — Wichita, Kansas, United States
• Study site — Elizabethtown, Kentucky, United States
• Study site — Lexington, Kentucky, United States
• Study site — Cumberland, Maryland, United States
• Study site — Frederick, Maryland, United States
• Study site — Huntsville, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.